Capturing fetal heart activity using ECG technology

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study aims to determine if a Holter ECG device can effectively capture fetal cardiac activity. Pregnant women between 32 weeks gestation and full term will have both a Holter ECG device and a standard Doppler Fetal Heart Rate (FHR) device attached to their abdomen for a 30-minute recording. The study will compare the data obtained from the Holter device with the standard Doppler FHR readings to validate the algorithm for extracting fetal heart rate from the ECG signals. The procedure will be conducted after routine antepartum testing, ensuring the safety and comfort of the participants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Singleton or twin pregnant women at 32 weeks gestation to full term after routine antepartum testing.

Exclusion Criteria:

* None.

Where it's running

• University of Washington
  Seattle, Washington, United States Recruiting

Study contacts

• Principal investigator: Martin G Frasch, MD, PhD — University of Washington
• Study coordinator: Martin G Frasch, MD, PhD
• Email: mfrasch@uw.edu
• Phone: 206-543-5892

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Digital fetal scalp stimulation during labor to identify fetal hypoxia

  This trial will see if a brief digital stimulation of the fetal scalp during labor can improve heart-rate tracings and scalp blood results for babies with suspicious or pathological cardiotocography.

  Recruiting at 2 sites Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Madrid and 1 other locations · NCT07035028

• Virtual reality versus in-person progressive muscle relaxation for pregnant people with preeclampsia

  This trial will test whether virtual reality–guided progressive muscle relaxation or face-to-face progressive muscle relaxation better reduces stress and improves maternal and fetal outcomes in hospitalized pregnant people with preeclampsia at or after 26 weeks.

  Recruiting Istanbul University - Cerrahpasa · Istanbul · NCT06893510

• Universal newborn hearing screening in Kenya using smartphone tests

  This study tests whether smartphone hearing screening can help identify ear infections and hearing loss in infants, including those exposed to HIV, over 6 months.

  Recruiting University of Washington · Nairobi · NCT07879326

• Greek Connections Program to nudge Greek members toward alcohol-free social activities

  This study tests whether increasing alcohol-free social events among fraternities and sororities can reduce heavy drinking and related problems in college students.

  Recruiting University of Washington · Seattle, Washington · NCT07839026

• Spinal Stimulation During Walking to See If Spasticity Lessens in Cerebral Palsy

  This study tests whether walking with non-invasive spinal stimulation reduces leg muscle tightness and improves walking in children and young adults with cerebral palsy.

  Recruiting University of Washington · Seattle, Washington · NCT07826494

• KABAWIL: Reducing Stigma for Indigenous Men and Healers in Guatemala

  A culturally tailored program called KABAWIL will be tried to see if it can reduce HIV-related and intersectional stigma and help Indigenous men and healers engage more with HIV prevention and care in Guatemala.

  Recruiting Phase 1 University of Washington · Seattle, Washington · NCT07786441

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.